# Transplant Hepatology * **Definition:** Transplant Hepatology is a subspecialty of hepatology that focuses on the evaluation, management, and care of patients with liver diseases who are candidates for liver transplantation, as well as the post-transplant care of liver transplant recipients. * **Taxonomy:** Specialties / Transplant Hepatology ## News * Selected news on the topic of **Transplant Hepatology**, for healthcare technology leaders * 1.2K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/9/2025 | [**Semaglutide Shows Promise for MASH Resolution, Severe Fibrosis: Naim Alkhouri, MD**](https://www.ajmc.com/view/semaglutide-set-to-benefit-patients-with-mash-severe-fibrosis-naim-alkhouri-md) | [[AJMC]] | | 4/23/2025 | [**Point of Care Hematology Diagnostics Market to Reach $3.0 Bn by 2027 in the short run and $3.6 Bn by 2030 Globally, at 5.8AGR: Allied Market Research**](https://www.globenewswire.com/news-release/2025/04/23/3066132/0/en/Point-of-Care-Hematology-Diagnostics-Market-to-Reach-3-0-Bn-by-2027-in-the-short-run-and-3-6-Bn-by-2030-Globally-at-5-8-CAGR-Allied-Market-Research.html) | [[Globe Newswire]] | | 4/3/2025 | [**Northwell team performs hospital's 1st pediatric heart transplant**](https://www.beckershospitalreview.com/cardiology/northwell-team-performs-hospitals-1st-pediatric-heart-transplant/) | [[Beckers Hospital Review]] | | 12/19/2024 | [**Tolerance Bio, Inc. Announces Scientific Advisory Board and Completion of $20.2 Million Seed Round to Advance Thymus-Based Therapies for Immune-Mediated Diseases**](http://www.businesswire.com/news/home/20241219611154/en/Tolerance-Bio-Inc.-Announces-Scientific-Advisory-Board-and-Completion-of-20.2-Million-Seed-Round-to-Advance-Thymus-Based-Therapies-for-Immune-Mediated-Diseases/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/10/2024 | [**Dallas Nephrology Associates' Journey to Value-Based Care**](https://www.ajmc.com/view/dallas-nephrology-associates-journey-to-value-based-care) | [[AJMC]] | | 12/3/2024 | [**Target RWE Highlights GLP-1 Receptor Agonists in Patients with Metabolic Dysfunction ...**](https://www.prnewswire.com/news-releases/target-rwe-highlights-glp-1-receptor-agonists-in-patients-with-metabolic-dysfunction-associated-steatotic-liver-disease-at-the-liver-meeting-2024-302319943.html) | [[PR Newswire]] | | 12/3/2024 | [**NDRI Elects Richard D. Hasz, Jr., to Board of Directors**](http://www.businesswire.com/news/home/20241203555444/en/NDRI-Elects-Richard-D.-Hasz-Jr.-to-Board-of-Directors/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 12/3/2024 | [**Bioprinting technique creates functional tissue 10x faster - Medical Xpress**](https://medicalxpress.com/news/2024-12-bioprinting-technique-functional-tissue-10x.html?deviceType=desktop) | [[MedicalXpress]] | | 11/25/2024 | [**HemoSonics Honored as One of the Fastest-Growing Companies in North America ... - Business Wire**](https://www.businesswire.com/news/home/20241125160459/en/HemoSonics-Honored-as-One-of-the-Fastest-Growing-Companies-in-North-America-on-the-2024-Deloitte-Technology-Fast-500) | [[Business Wire]] | | 11/25/2024 | [**HemoSonics Honored as One of the Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500**](http://www.businesswire.com/news/home/20241125160459/en/HemoSonics-Honored-as-One-of-the-Fastest-Growing-Companies-in-North-America-on-the-2024-Deloitte-Technology-Fast-500/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/18/2024 | [**The Last First Disruption - A Chance for Hospitals to Thrive - Healthcare IT Today**](https://www.healthcareittoday.com/2024/11/18/the-last-first-disruption-a-chance-for-hospitals-to-thrive/) | [[Healthcare IT Today]] | | 11/1/2024 | [**The Boston Globe Explores How Companies Are Working to Advance Medicine and Highlight Innovation at First Annual Future Of Medicine Event**](https://www.prnewswire.com/news-releases/the-boston-globe-explores-how-companies-are-working-to-advance-medicine-and-highlight-innovation-at-first-annual-future-of-medicine-event-302293398.html) | [[PR Newswire]] | | 10/31/2024 | [**Blood Plasma Market to Grow by USD 15.9 Billion (2024-2028) as Innovative Solutions ...**](https://www.prnewswire.com/news-releases/blood-plasma-market-to-grow-by-usd-15-9-billion-2024-2028-as-innovative-solutions-address-global-blood-shortage-report-highlights-ais-impact-on-market-trends---technavio-302292454.html) | [[PR Newswire]] | | 10/21/2024 | [**Philadelphia-area coalition announces the end of race adjustments in four clinical decision ...**](https://www.prnewswire.com/news-releases/philadelphia-area-coalition-announces-the-end-of-race-adjustments-in-four-clinical-decision-support-tools-used-in-lung-kidney-and-ob-gyn-care-302281761.html) | [[PR Newswire]] | | 10/9/2024 | [**CareDx Appoints Jing Huang Chief Data and AI Officer**](http://www.businesswire.com/news/home/20241009918561/en/CareDx-Appoints-Jing-Huang-Chief-Data-and-AI-Officer/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/9/2024 | [**CareDx Appoints Jing Huang Chief Data and AI Officer**](http://www.businesswire.com/news/home/20241009918561/en/CareDx-Appoints-Jing-Huang-Chief-Data-and-AI-Officer/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 10/9/2024 | [**CareDx Appoints Jing Huang Chief Data and AI Officer - Business Wire**](https://www.businesswire.com/news/siliconvalley/20241009918561/en) | [[Business Wire]] | | 9/17/2024 | [**InVita Healthcare Technologies, Albany Med Health System, the Center for Donation and Transplant, and ConnectLife Partner to Streamline Organ and Tissue Donation Referral Process**](https://www.prnewswire.com/news-releases/invita-healthcare-technologies-albany-med-health-system-the-center-for-donation-and-transplant-and-connectlife-partner-to-streamline-organ-and-tissue-donation-referral-process-302250635.html) | [[PR Newswire]] | | 9/11/2024 | [**KFSHRC Anuncia Parceria Estrategica para 2024 NYC C3 Summit Davos of Healthcare**](https://www.globenewswire.com/news-release/2024/09/11/2944777/0/pt/KFSHRC-Anuncia-Parceria-Estrat%C3%A9gica-para-2024-NYC-C3-Summit-Davos-of-Healthcare.html) | [[Globe Newswire]] | | 9/10/2024 | [**FDA Grants 510(k) Clearance to Sonic Incytes' Velacur® Determined Fat Fraction (VDFF), a breakthrough for patients with MASLD and MASH**](http://www.businesswire.com/news/home/20240910410138/en/FDA-Grants-510-k-Clearance-to-Sonic-Incytes-Velacur%C2%AE-Determined-Fat-Fraction-VDFF-a-breakthrough-for-patients-with-MASLD-and-MASH/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/10/2024 | [**FDA Grants 510(k) Clearance to Sonic Incytes' Velacur® Determined Fat Fraction (VDFF), a breakthrough for patients with MASLD and MASH**](http://www.businesswire.com/news/home/20240910410138/en/FDA-Grants-510-k-Clearance-to-Sonic-Incytes-Velacur%C2%AE-Determined-Fat-Fraction-VDFF-a-breakthrough-for-patients-with-MASLD-and-MASH/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 9/4/2024 | [**Avivo Biomedical Inc. Appoints Rob Carroll MD as Chief Medical Officer**](http://www.businesswire.com/news/home/20240904247126/en/Avivo-Biomedical-Inc.-Appoints-Rob-Carroll-MD-as-Chief-Medical-Officer/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 8/5/2024 | [**Renowned surgical oncologist takes leadership role at NYU Grossman Long Island School of Medicine**](https://www.news-medical.net/news/20240805/Renowned-surgical-oncologist-takes-leadership-role-at-NYU-Grossman-Long-Island-School-of-Medicine.aspx) | [[News Medical Net]] | | 7/17/2024 | [**Vaniam Group™ Welcomes Christa Gott as Senior Vice President of Business Strategy**](https://www.prnewswire.com/news-releases/vaniam-group-welcomes-christa-gott-as-senior-vice-president-of-business-strategy-302199534.html) | [[PR Newswire]] | | 7/4/2024 | [**Transplant Box Market size is set to grow by USD 2.39 billion from 2024-2028, Increasing prevalence of chronic disorders boost the market, Technavio**](https://www.prnewswire.com/news-releases/transplant-box-market-size-is-set-to-grow-by-usd-2-39-billion-from-2024-2028--increasing-prevalence-of-chronic-disorders-boost-the-market-technavio-302188853.html) | [[PR Newswire]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Lawson Health Research Institute**: Successfully performed Canada's first transplant using abdominal normothermic regional perfusion, enhancing organ availability. - **Naim Alkhouri**: Chief Medical Officer and Chief of Transplant Hepatology at Arizona Liver Health, directing the Fatty Liver Program. - **Bridge to Life Ltd**: A global leader in organ preservation solutions, collaborating with ULS Coimbra to improve liver preservation for transplantation. - **Renown Health**: Opened the Renown Transplant Institute to provide essential services for end-stage kidney disease patients. - **Paragonix Technologies**: Develops organ preservation technologies, including the LIVERguard system for liver transplants. - **Avivo Biomedical Inc.**: A company focused on innovative technologies for organ transplantation, including converting blood types to universal donor types. - **ChristianaCare**: A healthcare system that has appointed a chief advanced practice officer to enhance its transplant services. - **CareDx, Inc.**: A company focused on enhancing organ transplant matching through advanced HLA genotyping technologies. - **AlloSource**: A leading human tissue provider focused on creating innovative allografts to improve patient outcomes. - **Vascular Perfusion Solutions, Inc.**: A company focused on organ donation and transplantation, recently appointing Dr. Thomas C. Mayes as Interim Chairman. - **Resolution Therapeutics Limited**: A company developing regenerative macrophage therapy for end-stage liver disease. - **Albany Med Health System**: Partnered with InVita Healthcare Technologies and others to implement advanced technology for organ and tissue donation. - **Bridge to Life Ltd.**: A company that enhances organ preservation technology, recently acquiring the VitaSmart™ system to improve transplantation outcomes. - **Texas Children's Hospital**: One of the largest pediatric heart transplant programs in the U.S., known for its high success rates and innovative care. - **Evergreen Nephrology**: Introduced a new category for chronic kidney disease management, emphasizing early nephrology intervention. - **HemoSonics**: Develops the Quantra Hemostasis System for rapid blood analysis, crucial for surgeries including liver transplants. - **NYU Langone Health**: A leading institution in lung transplantation, recognized for performing the first fully robotic lung transplant in the U.S. - **Tolerance Bio**: A company developing therapies to preserve and manipulate the thymus for immune diseases. ### Partnerships and Collaborations - **Paragonix Technologies and HonorBridge**: Partnered to utilize LIVERguard technology for improved liver preservation during transplants. - **Bridge to Life Ltd and ULS Coimbra**: Collaboration to enhance liver preservation techniques and raise awareness of innovative transplantation procedures. - **Terasaki Institute**: Received NIH funding to enhance organ transplantation research and develop a multi-organs-on-a-chip platform. - **Guidehouse and U.S. Department of Health and Human Services**: Contract to modernize the organ transplant system, focusing on improving financial services and patient outcomes. - **CareDx and Dovetail Genomics**: Strategic partnership to enhance HLA genotyping for organ transplant matching. - **Intermountain Health**: Developed a risk score assessment tool for predicting cardiac events in kidney transplant candidates. - **Signet Healthcare Partners and Paragonix Technologies**: Investment and strategic guidance to enhance organ transplantation technology. - **Albany Med Health System and InVita Healthcare Technologies**: Implemented iReferral technology to streamline organ and tissue donation processes. - **InVita Healthcare Technologies, DonorConnect, Specialist Direct**: Launched an interoperability solution to automate reporting of diagnostic tests for organ donation. - **Sharp HealthCare and Palomar Health**: Partnering to improve medical service access and enhance transplant services. - **University of Vermont Health Network**: Partnered with InVita Healthcare Technologies and others to launch iReferral, an automated organ and tissue donation process. - **Albany Med Health System**: Implemented iReferral technology to streamline organ and tissue donation processes across its hospitals. - **West Virginia University Health System**: Collaborated with InVita Healthcare Technologies to implement iReferral technology for improving organ donation processes. - **CareDx**: Announced enhancements to its QTYPE solution for rapid deceased donor HLA typing, showcasing at the ASHI meeting. - **CaroMont Health, InVita Healthcare Technologies, LifeShare Carolinas**: Collaborated to launch iReferral, an electronic organ and tissue donor referral system to improve efficiency in organ donation. - **CareDx and TC BioPharm**: A strategic partnership to conduct pharmacokinetic analysis in the ACHIEVE clinical trial for cell therapy in blood cancers. - **Ossium Health**: Sources bone marrow from organ donors through partnerships with 27 Organ Procurement Organizations. - **WVU Medicine, InVita Healthcare Technologies, Lifeline of Ohio**: Collaborated to launch iReferral, a technology to streamline organ and tissue donation referrals, enhancing regulatory compliance and efficiency. - **Strive Health and Nephrologists**: Collaborating to address challenges faced by kidney disease patients through value-based care. - **BSF Enterprise and University of Montreal**: A research partnership to develop innovative corneal treatments addressing donor shortages. ### Innovations, Trends, and Initiatives - **LIVERguard System**: An innovative organ preservation system that enhances liver transplant outcomes. - **LIVERguard Technology**: A breakthrough in liver preservation that provides controlled hypothermic environments and real-time data monitoring during transplantation. - **Robotic Liver Transplantation**: KFSHRC performed the world's first fully robotic left lobe liver transplant, enhancing surgical precision and recovery. - **Robotic Transplant Surgery**: KFSHRC's pioneering work in robotic liver and heart transplants, showcasing advancements in surgical techniques. - **Outpatient Models**: Emerging as viable alternatives to traditional inpatient care for transplantation, potentially improving patient outcomes. - **Total Human Eye-allotransplantation Innovation Advancement (THEIA)**: A project aimed at developing techniques for eye transplantation, including nerve repair. - **Abdominal Normothermic Regional Perfusion**: A new technique that improves organ preservation and availability for transplantation, successfully implemented in Canada. - **AI in Transplantation**: CareDx is integrating AI into its solutions to improve patient outcomes and operational efficiency in transplant care. - **GUARDIAN-Liver Registry**: An initiative by Paragonix Technologies to evaluate the effectiveness of new liver preservation technologies compared to traditional methods. - **OPTN Modernization Initiative**: Aims to enhance accountability and performance in organ donation and transplantation through technology and data transparency. - **Prospera Lung Test**: A non-invasive monitoring tool for lung transplant patients, receiving CMS coverage for its ability to detect rejection and complications. - **Quantra Hemostasis System**: HemoSonics' system provides rapid blood analysis for surgical procedures, including liver transplants, improving patient care. - **eGenesis**: Pioneering xenotransplantation with successful porcine kidney transplants and a $191 million Series D financing round. - **Proposed Rule for HIV-positive Donors**: A proposed rule by the Biden administration to streamline organ donation criteria for HIV-positive donors, enhancing access to transplantation. - **AI in Healthcare**: Growing applications in optimizing organ transplantation and improving tumor removal accuracy, though facing skepticism regarding privacy and bias. - **Robotic Double Lung Transplant**: NYU Langone Health performed the first fully robotic double lung transplant, showcasing advancements in minimally invasive surgical techniques. - **Telepathology Interface**: A new interface that streamlines organ evaluation by providing real-time delivery of biopsy results. - **VitaSmart™ System**: A new organ preservation technology aimed at enhancing transplantation outcomes, with FDA submission planned for early 2025. - **iReferral Technology**: Implemented by Albany Medical Center to improve compliance with organ donation regulations and streamline notifications. - **iReferral**: An automated system replacing manual donor notification processes, aimed at improving organ donation efficiency. ### Challenges and Concerns - **Organ Shortages**: A significant challenge in transplant hepatology, particularly affecting pediatric acute liver failure patients who often do not receive timely transplants. - **Disparities in Transplantation**: Efforts are ongoing to address disparities in access to kidney transplants among different populations. - **Healthcare Costs**: The need for innovative solutions to reduce healthcare costs while improving patient outcomes in transplant care. - **Patient Education and Engagement**: Ensuring patients are well-informed about their options and the importance of early referrals for transplantation remains a critical challenge. - **Disparities in Transplant Outcomes**: Research indicates that socioeconomic factors significantly impact mortality rates following hematopoietic cell transplantation. - **Recurrence of Hepatocellular Carcinoma (HCC)**: High recurrence rates post-treatment pose a challenge in managing HCC, necessitating ongoing research for standardized treatment protocols. - **Access to Care**: Underserved communities face barriers to timely access to kidney transplant evaluations and care. - **Increasing Organ Transplant Access (IOTA) Model**: Concerns raised by the American Hospital Association regarding potential flaws in the model's design affecting patient outcomes. - **Stigma and Health Disparities**: The proposed rule for HIV-positive donors aims to address stigma and improve health equity in organ transplantation. - **Organ Donation Process**: Despite technological advancements, challenges remain in ensuring timely and efficient organ donation referrals, impacting patient outcomes. - **Organ Shortage**: The global organ shortage crisis continues to be a significant challenge, with innovative solutions like xenotransplantation being explored. - **Socioeconomic Status Impact**: Research indicates that donor socioeconomic status may adversely affect stem cell quality and transplant outcomes. - **Regulatory Compliance**: Healthcare systems must navigate complex regulations while implementing new technologies for organ donation and transplantation. - **Outdated Software Systems**: The U.S. healthcare sector relies on outdated systems that hinder efficiency and security in organ transplantation processes. - **Bias in Medical AI**: Concerns about bias in algorithms affecting transplant wait times and outcomes, particularly for marginalized groups. - **Antibiotic Resistance in Cirrhosis Patients**: Research highlights the need for improved antibiotic targeting due to rising antibiotic resistance linked to bacterial changes in cirrhosis patients. - **Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)**: A growing health concern affecting millions, necessitating reliable non-invasive tests for liver fat measurement. ## Related Topics [[Pediatric Transplant Hepatology]]; [[Transplant Cardiology]]